A Study Comparing Amounts of 2 Different Forms of Tafamidis (PF-6291826) in the Blood
Status:
Completed
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
2 different formulations and doses of tafamidis will be compared. All subjects will receive
both doses/formulations. Subjects will take tafamidis for 7 days, on the first 2 days they
will take tafamidis twice, 12 hours apart and then once a day for the next 5 days. Subjects
will be fasted before taking the drug. Blood samples will be taken to measure the amount of
tafamidis starting on day 7 and ending on day 8. At least 16 days after the first
formulation/dose is given, all subjects will repeat the procedure with the other
formulation/dose.